✦ LIBER ✦

Mitomycin + capecitabine a mighty combo for resistant, metastatic breast cancer

Book ID: 120849187
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2006
Weight: 133 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200615680-00037

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Photoeruption in a patient treated with

Photoeruption in a patient treated with capecitabine (Xeloda) for metastatic breast cancer∗

✍ Andrea Willey; Earl J. Glusac; Jean L. Bolognia 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Capecitabine and mitomycin C as third-li

Capecitabine and mitomycin C as third-line therapy for patients with metastatic colorectal cancer resistant to fluorouracil and irinotecan

✍ Chong, G; Dickson, J L B; Cunningham, D; Norman, A R; Rao, S; Hill, M E; Price, 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 89 KB

Lichenoid photosensitive eruption due to

Lichenoid photosensitive eruption due to capecitabine chemotherapy for metastatic breast cancer

✍ J. S. Hague; A. Ilchyshyn 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 201 KB

Ixabepilone: a new treatment option for

Ixabepilone: a new treatment option for resistant metastatic breast cancer

✍ Darrel W. Cleere 📂 Article 📅 2009 🏛 Frontline Medical Communications, Inc. 🌐 English ⚖ 162 KB

Dose-Adjusting Capecitabine Minimizes Ad

Dose-Adjusting Capecitabine Minimizes Adverse Effects While Maintaining Efficacy: A Retrospective Review of Capecitabine for Metastatic Breast Cancer

✍ Robert Leonard; Bryan T. Hennessy; Joanne L. Blum; Joyce O'Shaughnessy 📂 Article 📅 2011 🏛 CIG Media Group, LP. 🌐 English ⚖ 418 KB

Phase II Trial of Capecitabine and Weekl

Phase II Trial of Capecitabine and Weekly Docetaxel for Metastatic Castrate Resistant Prostate Cancer

✍ Vaishampayan, Ulka N.; Marur, Shanthi; Heilbrun, Lance K.; Cher, Michael L.; Dic 📂 Article 📅 2009 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 480 KB